person
Lorenzo A.
- Country
- Italy
- Department
- SOD Oncologia
Research Overview
assignment
123
Clinical Trials ·
- Phase 1 Study of SHP2 Inhibitor BBP-398 and KRAS-G12C Inhibitor Sotorasib in Advanced Solid Tumors with KRAS-G12C Mutation
- Evaluation of [Main Substance] in Combination with Other Agents in Patients with Advanced Solid Tumors
- Phase 1/1b Evaluation of IAM1363 in Patients with Relapsed/Refractory HER2-Altered Malignancies
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
658
Sites with multiple studies
Has run more than one trial at 658 of 1030 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating advanced colorectal cancer and gastrointestinal malignancies, with particular focus on molecular-targeted therapies.
- Metastatic colorectal cancer treatment strategies
- MGMT-silenced tumor approaches
- HER2-positive gastric cancer interventions
Thoracic Oncology
Expertise in managing non-small cell lung cancer across various stages and molecular subtypes, including novel therapeutic combinations.
- EGFR-mutated lung cancer treatments
- Small cell lung cancer therapies
- Immunotherapy combinations
Genitourinary Cancers
Focus on treating urological malignancies with innovative therapeutic approaches and targeted treatments.
- Advanced renal cell carcinoma management
- Urothelial carcinoma treatments
- Metastatic prostate cancer interventions
Hepatobiliary Oncology
Specialized in treating liver and biliary tract cancers using multi-modal therapeutic strategies.
- Advanced hepatocellular carcinoma
- Cholangiocarcinoma treatments
- Immunotherapy applications
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.